Contract Awarded For 1113626 Acquisition Of Exclusive Roche Medications - Subcutaneous Atezolizumab - 2026
1113626 Acquisition Of Exclusive Roche Medications - Subcutaneous Atezolizumab - 2026
value Of The Result:
winner Selection Date : 25/02/2026
dat
TK ID 528683213
Document Type
Contract Awards
Tender Summary
Contract Awarded For 1113626 Acquisition Of Exclusive Roche Medications - Subcutaneous Atezolizumab - 2026
1113626 Acquisition Of Exclusive Roche Medications - Subcutaneous Atezolizumab - 2026
value Of The Result:
winner Selection Date : 25/02/2026
dat